LeMaitre Vascular, Inc. (NasdaqGM:LMAT) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its common stock. The repurchase program is valid till February 21, 2025, unless extended.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.8 USD | -2.17% | +0.89% | +14.16% |
Apr. 29 | North American Morning Briefing : Investors Brace -2- | DJ |
Apr. 26 | Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.16% | 1.49B | |
+7.15% | 220B | |
+6.60% | 183B | |
+9.86% | 133B | |
+24.32% | 107B | |
-0.95% | 63.05B | |
+11.04% | 51.74B | |
+4.81% | 50.47B | |
-1.43% | 40.91B | |
+24.40% | 31.91B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- LeMaitre Vascular, Inc. announces an Equity Buyback for $50 million worth of its shares.